CMS certification 390027
Temple University Hospital
3401 North Broad Street, Philadelphia, PA 19140
Temple University Hospital has a CMS overall rating of 4 out of 5 stars. 64% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 1. Emergency patients spend a median of 4 h 3 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 721 completed surveys, 12% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | PA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 345 visits sampled · US median for EDs of the same volume: 3 h 21 min | 4 h 3 min | 3 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 11 visits sampled | 5 h 14 min | 4 h 57 min | 4 h 17 min |
| Left before being seen Lower is better · 161,181 patients | 11% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 526 patients | 60% | 60% | 65% |
How Temple University Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Temple University HospitalThis hospital | 4/5 | 64% | 4 h 3 min | 6 better 1 worse |
| Jefferson Einstein Philadelphia HospitalSame city | 3/5 | 59% | 4 h 28 min | 2 better 2 worse |
| Nazareth HospitalSame city | 2/5 | 52% | 3 h 42 min | 1 better 1 worse |
| Roxborough Memorial HospitalSame city | 2/5 | 57% | 3 h 6 min | 1 worse |
| Temple Health - Chestnut Hill HospitalSame city | 2/5 | 50% | 3 h 54 min | 1 better 2 worse |
| Jefferson Health- NortheastSame city | 2/5 | 62% | 5 h 16 min | 2 better 4 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Philadelphia.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 4,885 cases | Too few cases | 3% | 3.9% |
| Heart attack 96 cases | Too few cases | 12.1% | 11.9% |
| Heart failure 480 cases | Too few cases | 8.6% | 11.1% |
| Pneumonia 337 cases | Too few cases | 14.8% | 15.2% |
| Stroke 488 cases | Too few cases | 8.3% | 11.9% |
| COPD 287 cases | Too few cases | 6.6% | 8.6% |
| Heart bypass surgery (CABG) 70 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.99 likely 0.75 – 1.22 | 1 |
| After hip or knee replacement 195 cases | Too few cases | 4.5% | 4.1% |
| Deaths after a serious but treatable surgical complication 98 cases | No different | 194.9 per 1,000 likely 148.67 per 1,000 – 241.13 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 7,676 cases | No different | 0.52 per 1,000 likely 0.09 per 1,000 – 0.95 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 9,057 cases | No different | 0.13 per 1,000 likely 0 per 1,000 – 0.31 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 9,949 cases | No different | 0.22 per 1,000 likely 0.04 per 1,000 – 0.4 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,671 cases | No different | 2.55 per 1,000 likely 1.22 per 1,000 – 3.88 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 803 cases | No different | 1.77 per 1,000 likely 0.48 per 1,000 – 3.07 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 808 cases | No different | 10.48 per 1,000 likely 5.54 per 1,000 – 15.42 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,859 cases | No different | 3.65 per 1,000 likely 1.89 per 1,000 – 5.42 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 856 cases | No different | 4.55 per 1,000 likely 1.65 per 1,000 – 7.44 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 358 cases | No different | 1.52 per 1,000 likely 0.1 per 1,000 – 2.94 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,604 cases | No different | 1.94 per 1,000 likely 1.03 per 1,000 – 2.85 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.66 likely 0.44 – 0.95 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.59 likely 0.38 – 0.88 | 1 |
| Surgical site infections after colon surgery | Better | 0.26 likely 0.04 – 0.85 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.72 likely 0.04 – 3.56 | 1 |
| MRSA bloodstream infections | No different | 0.78 likely 0.44 – 1.28 | 1 |
| C. diff intestinal infections | Better | 0.39 likely 0.28 – 0.52 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 294 cases | Too few cases | 14.5% | 14.4% |
| Readmitted after heart failure 1,587 cases | Too few cases | 21.3% | 21.3% |
| Readmitted after pneumonia 873 cases | Too few cases | 16.7% | 17.3% |
| Readmitted after COPD 804 cases | Too few cases | 19.2% | 20% |
| Readmitted after heart bypass surgery 109 cases | Too few cases | 10.8% | 11% |
| Readmitted after hip or knee replacement 199 cases | Too few cases | 5% | 5.8% |
| Days back in hospital after a heart attack 124 cases | Too few cases | -18.4 days per 100 | — |
| Days back in hospital after heart failure 600 cases | Too few cases | 3.4 days per 100 | — |
| Days back in hospital after pneumonia 353 cases | Too few cases | -9.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 713 cases | No different | 12.6 per 1,000 likely 9.6 per 1,000 – 16.5 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,422 cases | No different | 10.2 per 100 likely 8.9 per 100 – 11.6 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,422 cases | Better | 4.3 per 100 likely 3.5 per 100 – 5.3 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 638 cases | No different | 0.8 likely 0.6 – 1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
1,911 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 53 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Internal Medicine | 404 |
| Emergency Medicine | 194 |
| Surgery | 154 |
| Anesthesiology | 121 |
| Obstetrics & Gynecology | 82 |
| Diagnostic Radiology | 72 |
| Nurse Anesthetist, Certified Registered | 71 |
| Pulmonary Disease | 53 |
| Anatomic Pathology & Clinical Pathology | 38 |
| Family | 38 |
| Physician Assistant | 38 |
| Orthopaedic Surgery | 35 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.4M
- 2020 $381,613
- 2021 $1.4M
- 2022 $1.4M
- 2023 $1.2M
- 2024 $1.5M
- 2025 $1.7M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $370,000 | 2 |
| Medical devices and supplies on long-term loan | $60,072 | 2 |
| Speaking, teaching and other services | $25,425 | 29 |
| Space rental and facility fees | $21,808 | 7 |
| Consulting fees | $3,000 | 1 |
| Travel and lodging | $1,545 | 3 |
| Education | $1,500 | 1 |
| Debt forgiveness | $741 | 4 |
| Food and beverage | $481 | 9 |
| Honoraria | $85 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Fisher & Paykel Healthcare Limited | $903,379 | 4 |
| Actelion Pharmaceuticals US, Inc. | $350,000 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $217,004 | 41 |
| AngioDynamics, Inc. | $60,000 | 1 |
| Mannkind Corporation | $39,551 | 4 |
| Enterra Medical, Inc. | $26,306 | 1 |
| Insulet Corporation | $23,500 | 23 |
| Biosense Webster, Inc. | $20,000 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| myAirvo3 (High Flow Nasal Therapy, HFNT) for COPD Patients in the Home FISHER & PAYKEL HEALTHCARE LIMITED · NCT05204888 | $876,000 |
| AN OPEN-LABEL, DOSE ESCALATION, PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TAK-676 AS A SINGLE AGE… Takeda Pharmaceuticals U.S.A., Inc. · NCT04420884 | $98,509 |
| ICON-1 PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF TREATMENT WITH MNKD-101, CLOFAZAMINE INHALATION SUSPENSION Mannkind Corporation · NCT06418711 | $39,551 |
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants w… Takeda Pharmaceuticals U.S.A., Inc. | $28,831 |
| Closed loop oxygen control in COPD patients treated with nasal high flow in the hospital FISHER & PAYKEL HEALTHCARE LIMITED · NCT07222410 | $27,379 |
| Navigate Enterra Medical, Inc. | $26,306 |
| AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION, PHASE 1A/1B STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TAK-5… Takeda Pharmaceuticals U.S.A., Inc. | $23,874 |
| A PHASE 1B/2 STUDY OF TAK-981 PLUS PEMBROLIZUMAB TO EVALUATE THE SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF THE COMBINATION IN PATIENTS WITH SEL… Takeda Pharmaceuticals U.S.A., Inc. | $19,903 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Temple University Hospital
Is Temple University Hospital a good hospital?
Temple University Hospital has a CMS overall rating of 4 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 6 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Temple University Hospital?
64% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 721 completed HCAHPS surveys.
How long is the wait in the Temple University Hospital emergency room?
Emergency patients spend a median of 4 h 3 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 11% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Temple University Hospital receive money from drug and device companies?
Drug and device makers reported $1.7M in payments to Temple University Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.